Profile: 20/20 GeneSystems, Inc. develops & delivers diagnostic products for the early detection of disease and the selecton & monitoring of opmtimum, personalized therapies. Our ErbBTest™ uses layered peptide arrays and layered expression scanning to profile tumors for response to drugs that target the ErbB1 & ErbB2 pathways. Our 20/20 Biocheck powder screening test kit provides a convenient tool for first responders investigating suspicious white powders.